Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 10133

BillFederalHouseIn Committee
To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to ensure cost sharing for a drug does not exceed the nationwide average of consumer purchase prices for such drug.
About This Bill
Committee
Latest Action · August 20, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced
August 20, 2026
Cosponsors (0)
None
View PDF ↗
SummaryFull TextCommentsAnnotations

Summary

Highlight any text to annotate
The Fair Prescription Pricing Act of 2026 caps what patients have to pay out of pocket for prescription drugs. Under this bill, health insurance plans and insurers cannot charge patients more in deductibles, copayments, or coinsurance than the nationwide average price consumers pay for a specific drug. The law applies to both group health plans and individual insurance coverage when medications are filled at in-network pharmacies, and it requires pharmacy benefit managers to follow the same pricing rules. The bill takes effect for plan years beginning after its enactment and uses existing government price survey data to determine what constitutes the nationwide average for each drug. This legislation aims to prevent patients from being overcharged by their insurance plans relative to what most Americans actually pay for the same medications.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.